Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TRILLION ENERGY’S WEST AKCAKOCA WELL ENTERS PRODUCTION (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Kalytera Therapeutics Inc V.CLAS.H

Alternate Symbol(s):  KALTF

Healthcare Biotechnology
Kalytera Therapeutics is committed to developing new treatments for a variety of diseases and disorders, by discovering, developing, manufacturing and delivering innovative human therapeutics.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSXV:CLAS.H)

Fundamentals Snapshot (TSXV:CLAS.H)

Current News (TSXV:CLAS.H)

IIROC Trading Halt - CLAS

Canada NewsWire July 20, 2022

Claritas Pharmaceuticals (TSXV:CLAS) approved to list on the OTCQB

John Ballem  April 7, 2022

Claritas Announces Approval from OTC to Up-List to OTCQB

GlobeNewswire April 7, 2022

Claritas Announces Approval from Australian Ethics Committee to Begin Phase 1 Trial of R-107

GlobeNewswire April 5, 2022

Claritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company's Phase 1 Clinical Study of R-107 and Closing of Financing

GlobeNewswire February 22, 2022

Claritas Anticipates Response from Australian Ethics Committee by February 18, 2022

GlobeNewswire February 9, 2022

Claritas Announces Revised, Improved Terms for Initial Tranche of Financing with Alumina Partners

GlobeNewswire January 26, 2022

Claritas Announces Letter of Intent to Acquire Worldwide Rights to R-107 for Treatment of Wound Healing, Skin Ulcers and Severe Burns

GlobeNewswire January 17, 2022

Claritas Announces New Registered and Records Office Address, Confirms its Management and Directors and Announces Terms of Initial Tranche of Equity Financing with Alumina Partners

GlobeNewswire January 17, 2022
View More News ››

Opinion & Analysis (TSXV:CLAS.H)

Buzz on the Bullboards: Mining Heats Up as Healthcare Makes Headlines

Stockhouse Editorial March 11, 2021

Buzz on the Bullboards: In the COVID Fallout, New Players Emerge

Stockhouse Editorial March 4, 2021

Buzz on the Bullboards: Eyes on Cannabis Rebound

Omri Wallach May 21, 2020

Buzz on the Bullboards: Big Last-Minute Moves

Omri Wallach December 12, 2019

New Cannabis CBD Patent Issued to Kalytera

Stockhouse Editorial July 4, 2018

New Cannabis CBD Patent Issued to Kalytera

Stockhouse Editorial April 23, 2018
View More Opinion ››

Bullboard Posts (TSXV:CLAS.H)

RE:Bob selling his house in California?

We really did fund a beautiful house for Bob. Living the dream Bob. Do you have any R107 in the wine fridge? 
losingmyshirt - 10 days ago

Bob selling his house in California?

https://www.realtor.com/realestateandhomes-detail/41-Thunderbird-Dr_Novato_CA_94949_M11917-09282
losingmyshirt - 10 days ago

CLAZF Up today

CLAZF up 7999900% today on a 10K share buy today at .08
Red~One - 13 days ago

RE:OH my. he has his eyes on you

R107 YUP.
losingmyshirt - March 7, 2023

RE:OH my. he has his eyes on you

WHAT COULD POSSIBLY GO WRONG?
losingmyshirt - February 18, 2023

OH my. he has his eyes on you

losingmyshirt - February 13, 2023
View more Bullboard ››

NeonMind Biosciences

NeonMind Biosciences

NeonMind Biosciences Inc is engaged in preclinical research to develop potential clinical treatments and wellness products to ...
View More »